Industry News, Trustworthy Insights

Popular Companies:

JP Morgan: Advisory on $170m Forbion Led Series B Investment Round in Beacon Therapeutics

JP Morgan played a pivotal role as the sole placement agent in Beacon Therapeutics’ recent achievement of securing $170 million during its Series B funding round.

JP Morgan Office. PHOTO: Getty Images
JP Morgan Office. PHOTO: Getty Images

Led by Forbion, a renowned life sciences venture capital firm, the investment will expedite the development of Beacon’s innovative ophthalmic gene therapies.

These include their leading asset,

More from Krugman Insights

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

[formidable id=3]